Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alfentanil for Sympathetic Responses in RSI
NCT01518608Phase 4Completed
- Sponsor
- Oslo University Hospital
- Start
- Sep 2009
- Primary completion
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of alfentanil in Anesthesia (7 arms), sponsored by Oslo University Hospital. Primary endpoints: Success rate of optimal blood pressure control (increase < 10%) and Success rate of perfect intubation conditions. Started Sep 2009; status: completed.
02
Drugs
alfentanil
03
Conditions
Anesthesia
Beyond the preview
Go deeper on NCT01518608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01518608.